Locilex® has demonstrated potent, bactericidal activity against gram-positive, gram-negative, aerobic, anerobic, and resistant bacteria. We believe this broad spectrum of activity, coupled with an excellent safety profile, and lack of systemic absorption, could allow Locilex® to become an important front-line treatment option across many mild and moderate skin and skin structure infections.